PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 84 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $73,000 | -60.3% | 172,643 | +10.0% | 0.00% | -100.0% |
| Q4 2015 | $184,000 | +30.5% | 157,013 | +13.5% | 0.00% | – |
| Q3 2015 | $141,000 | -18.0% | 138,288 | +5.5% | 0.00% | -100.0% |
| Q2 2015 | $172,000 | -9.9% | 131,131 | -7.2% | 0.00% | 0.0% |
| Q1 2015 | $191,000 | +25.7% | 141,281 | +29.0% | 0.00% | – |
| Q4 2014 | $152,000 | -5.0% | 109,481 | -7.0% | 0.00% | – |
| Q3 2014 | $160,000 | -19.6% | 117,696 | +11.2% | 0.00% | -100.0% |
| Q2 2014 | $199,000 | +22.1% | 105,796 | +23.4% | 0.00% | – |
| Q1 2014 | $163,000 | +27.3% | 85,710 | -6.9% | 0.00% | – |
| Q4 2013 | $128,000 | -3.8% | 92,040 | -2.6% | 0.00% | – |
| Q3 2013 | $133,000 | +11.8% | 94,540 | +2.7% | 0.00% | – |
| Q2 2013 | $119,000 | – | 92,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tappan Street Partners LLC | 11,593,530 | $7,049,000 | 20.61% |
| Bandera Partners LLC | 1,421,000 | $864,000 | 0.78% |
| Brown Advisory Securities, LLC | 580,000 | $353,000 | 0.08% |
| Sterling Global Strategies LLC | 20,000 | $12,000 | 0.06% |
| Freedom Investment Management, Inc. | 1,052,770 | $642,000 | 0.04% |
| BAXTER BROS INC | 150,500 | $92,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 576,897 | $351,000 | 0.01% |
| Ballentine Partners, LLC | 25,001 | $113,000 | 0.01% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 57,700 | $37,000 | 0.01% |
| Spark Investment Management LLC | 128,600 | $78,000 | 0.01% |